Posted inHealth and FitnessLife

Alzheimer’s Association Welcomes FDA Approval of Aducanumab

On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease. “This approval is a victory for people living with Alzheimer’s and their families,” said Harry Johns, Alzheimer’s Association president and chief executive officer. “This is the first FDA-approved drug that […]